Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tweed Renaissance Investors Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 62
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 33
Rounds per year 3.10
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.47
Exits 3
Key employees 4
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Software
  • Medical
Summary

Tweed Renaissance Investors Capital appeared to be the VC, which was created in 2004. The leading representative office of defined VC is situated in the Melrose. The fund was located in Europe if to be more exact in United Kingdom.

The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Computer, Software. Among the most popular portfolio startups of the fund, we may highlight My1Login, Exterity, Inquisitive Systems. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Tweed Renaissance Investors Capital, startups are often financed by Barwell Plc, Archangels, Highland Capital Partners. The meaningful sponsors for the fund in investment in the same round are Barwell Plc, Archangels, Highland Capital Partners. In the next rounds fund is usually obtained by Scottish Investment Bank, Archangels, Barwell Plc.

Besides them, we counted 4 critical employees of this fund in our database.

The fund is constantly included in 2-6 deals per year. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2016. This Tweed Renaissance Investors Capital works on 21 percentage points less the average amount of lead investments comparing to the other organizations.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bewa7er Bilbao, Pais Vasco, Spain
CapXM -
China Evergrande Group China, Guangdong, Guangzhou
Cloudstone Venture -
District 2 Capital -
Fullshare Holdings China, Hong Kong, Hong Kong Island
GMO VenturePartners Chiyoda, Japan
Handmade Ventures California, San Mateo, United States
HB Investment Seoul, Seoul-t'ukpyolsi, South Korea
Hunan Zhijia Touzi -
Ingenio Canada, Montréal, Quebec
ISAO -
Leader Ventures California, Menlo Park, United States
Ontario Scale-Up Vouchers Program (OSVP) -
Oyster Angel Fund -
Silfurberg Gullbringusysla, Iceland, Reykjavík
Susquehanna Growth Equity Pennsylvania, Philadelphia, United States
Vaizra Capital New York, New York, United States
Walgreens Boots Alliance Deerfield, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

HonuWorx

Autonomous Vehicles
Marine Technology
Robotics
Software
09 Sep 2024 Aberdeen, Scotland, United Kingdom

ŌGI Bio

Biopharma
Biotechnology
$890K18 Jun 2024 -

Glen Clova Scientific

$5M24 Apr 2024 Scotland, Indiana, United States

Carcinotech

Medical
$5M29 Jan 2024 -

Heero Technologies

Renewable Energy
Semiconductor
Service Industry
$753K03 Oct 2023 Dundee City, Dundee, United Kingdom

Heero Technologies

Renewable Energy
Semiconductor
Service Industry
19 Apr 2023 Dundee City, Dundee, United Kingdom

ŌGI Bio

Biopharma
Biotechnology
$1M16 May 2022 -

Carcinotech

Medical
$2M25 Apr 2022 -

Aveni

Information Technology
Video Conferencing
$1M21 Jun 2021 City of Edinburgh, Scotland, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tweed Renaissance Investors Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 62
Average round size 1M
Rounds per year 3.10
Peak activity year 2024
Lead investments 10
Follow on index 0.47
Exits 3
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

HonuWorx

Autonomous Vehicles
Marine Technology
Robotics
Software
09 Sep 2024 Aberdeen, Scotland, United Kingdom

ŌGI Bio

Biopharma
Biotechnology
$890K18 Jun 2024 -

Glen Clova Scientific

$5M24 Apr 2024 Scotland, Indiana, United States

Carcinotech

Medical
$5M29 Jan 2024 -

Heero Technologies

Renewable Energy
Semiconductor
Service Industry
$753K03 Oct 2023 Dundee City, Dundee, United Kingdom

Heero Technologies

Renewable Energy
Semiconductor
Service Industry
19 Apr 2023 Dundee City, Dundee, United Kingdom

ŌGI Bio

Biopharma
Biotechnology
$1M16 May 2022 -

Carcinotech

Medical
$2M25 Apr 2022 -

Aveni

Information Technology
Video Conferencing
$1M21 Jun 2021 City of Edinburgh, Scotland, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: